FDA Inspection 1251223 — Biobank Co., Ltd.
The FDA completed an inspection of Biobank Co., Ltd. on Sep 4, 2024 in Okayama. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 4, 2024
- Fiscal Year
- 2024
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Okayama (Japan)
Citations
| ID | CFR | Description |
|---|---|---|
| 15532 | 21 CFR 111.255(b) | Batch record - complete |
| 15882 | 21 CFR 111.75(h) | Tests, examinations - scientifically valid |
| 22847 | 21 CFR 111.70(e) | Specifications - finished dietary supplement |